Georgios Grammatikos, Julia Dietz, Nerea Ferreirós Bouzas, Alexander Koch, Georg Dultz, Dimitra Bon, Ioannis Karakasiliotis, Thomas Lutz, Gaby Knecht, Peter Gute, Eva Herrmann, Stefan Zeuzem, Penelope Mavromara, Christoph Sarrazin, Josef Pfeilschifter
- Hepatitis C virus (HCV) substantially affects lipid metabolism, and remodeling of sphingolipids appears to be essential for HCV persistence in vitro. The aim of the current study is the evaluation of serum sphingolipid variations during acute HCV infection. We enrolled prospectively 60 consecutive patients with acute HCV infection, most of them already infected with human immunodeficiency virus (HIV), and serum was collected at the time of diagnosis and longitudinally over a six-month period until initiation of antiviral therapy or confirmed spontaneous clearance. Quantification of serum sphingolipids was performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Spontaneous clearance was observed in 11 out of 60 patients (18.3%), a sustained viral response (SVR) in 43 out of 45 patients (95.5%) receiving an antiviral treatment after follow-up, whereas persistence of HCV occurred in six out of 60 patients (10%). C24-ceramide (C24-Cer)-levels increased at follow-up in patients with spontaneous HCV eradication (p < 0.01), as compared to baseline. Sphingosine and sphinganine values were significantly upregulated in patients unable to clear HCV over time compared to patients with spontaneous clearance of HCV infection on follow-up (p = 0.013 and 0.006, respectively). In summary, the persistence of HCV after acute infection induces a downregulation of C24Cer and a simultaneous elevation of serum sphingosine and sphinganine concentrations.
MetadatenAuthor: | Georgios Grammatikos, Julia DietzORCiDGND, Nerea Ferreirós BouzasORCiDGND, Alexander Koch, Georg DultzORCiDGND, Dimitra Bon, Ioannis Karakasiliotis, Thomas Lutz, Gaby Knecht, Peter Gute, Eva HerrmannORCiDGND, Stefan ZeuzemORCiDGND, Penelope Mavromara, Christoph SarrazinGND, Josef PfeilschifterGND |
---|
URN: | urn:nbn:de:hebis:30:3-422706 |
---|
URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926455 |
---|
DOI: | https://doi.org/10.3390/ijms17060922 |
---|
ISSN: | 1661-6596 |
---|
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/27304952 |
---|
Parent Title (English): | International journal of molecular sciences |
---|
Publisher: | Molecular Diversity Preservation International |
---|
Place of publication: | Basel |
---|
Contributor(s): | Johannes Haybäck |
---|
Document Type: | Article |
---|
Language: | English |
---|
Date of Publication (online): | 2016/11/28 |
---|
Date of first Publication: | 2016/06/13 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2016/11/28 |
---|
Tag: | HIV; angiopoietin-like 3 (ANGPTL3); biomarker; hepatitis C; sphingolipid |
---|
Volume: | 17 |
---|
Issue: | 6, 922 |
---|
Page Number: | 12 |
---|
First Page: | 1 |
---|
Last Page: | 12 |
---|
Note: | © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
---|
HeBIS-PPN: | 421369523 |
---|
Institutes: | Medizin / Medizin |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung 4.0 |
---|